Nakashima M, Kong Y M, Wan Q, Davies T F
Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:46-51. doi: 10.1055/s-0029-1211701.
Murine experimental autoimmune thyroiditis (EAT) is a well established model of autoimmune disease initiated by immunization with thyroglobulin. We have previously analyzed the T cell receptor (TcR) V gene families used by the intrathyroidal lymphocytic infiltrate in CBA/J mice with well established thyroiditis EAT and have implicated T cells expressing the mTcR V beta 13 gene family. We have now proceeded to examine the time course of mTcR V gene family use following immunization with mTg. We used a radiolabelled RT-PCR technique with oligonucleotides detecting 17 mouse TcR V beta gene families to examine the heterogeneity of the amplified V-D-J (CDR3) fragments. As previously, the TcR V beta 13 amplifications showed the expression of two similar homogeneous CDR3 sizes consistent with two clonally expanded T cell populations. However, such T cell clonal expansion was observed to peak at day 25 and by 90 days had markedly diminished despite the continuing presence of extensive histologic infiltration. An additional immunization with mTg at 63 days failed to maintain the mTcR V beta 13 clonal presence. Further confirmation of these observations was obtained by direct analysis of intrathyroidal T cells rescued from mice with EAT. Such intrathyroidal T cells, 25 days after mTg, demonstrated a marked increase in mTcR V13 expressing T cells to 9.4% compared to 2% of T cells in peripheral blood. It appeared, therefore, that in EAT the accumulation of V13 expressing T cells was a transient phenomenon which peaked at 25 days after immunization. The persistence of an intrathyroidal infiltration indicated that such T cells must have been accompanied by the accumulation and recruitment of additional selected bystander T cells. Such non-specific T cells may also have an integral role in the progression of autoimmune thyroiditis.
小鼠实验性自身免疫性甲状腺炎(EAT)是一种通过用甲状腺球蛋白免疫引发的成熟的自身免疫性疾病模型。我们之前分析了患有成熟甲状腺炎EAT的CBA/J小鼠甲状腺内淋巴细胞浸润所使用的T细胞受体(TcR)V基因家族,并发现表达mTcR Vβ13基因家族的T细胞与之相关。我们现在继续研究用mTg免疫后mTcR V基因家族使用的时间进程。我们使用放射性标记的RT-PCR技术,用检测17个小鼠TcR Vβ基因家族的寡核苷酸来检查扩增的V-D-J(CDR3)片段的异质性。如前所述,TcR Vβ13扩增显示出两种相似的均一CDR3大小的表达,这与两个克隆扩增的T细胞群体一致。然而,这种T细胞克隆扩增在第25天达到峰值,到90天时尽管仍有广泛的组织学浸润持续存在,但已明显减少。在第63天用mTg再次免疫未能维持mTcR Vβ13克隆的存在。通过直接分析从患有EAT的小鼠中拯救出的甲状腺内T细胞,获得了对这些观察结果的进一步证实。在mTg注射25天后,这种甲状腺内T细胞显示出表达mTcR V13的T细胞显著增加至9.4%,而外周血中T细胞仅为2%。因此,在EAT中,表达V13的T细胞的积累似乎是一种短暂现象,在免疫后第25天达到峰值。甲状腺内浸润的持续存在表明,此类T细胞必定伴随着其他被选择的旁观者T细胞的积累和募集。这种非特异性T细胞在自身免疫性甲状腺炎的进展中可能也起着不可或缺的作用。